Cano Health Inc. (NYSE:CANO) shares traded -10.42% lower at $1.29 on Wall Street last session.
In accordance with the data, 10 analysts cover Cano Health Inc. (NYSE:CANO). The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $7.00 and a low of $1.00, we find $2.75. Given the previous closing price of $1.44, this indicates a potential upside of 90.97 percent. CANO stock price is now 6.40% away from the 50-day moving average and -56.39% away from the 200-day moving average. The market capitalization of the company currently stands at $707.78M.
25-cent Stock Takes $11T Commodities Sector Digital
One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.
All the details are in the FREE online report you can get here.
Sponsored
It has been rated a hold by 5 analysts and a buy by 3. Brokers who have rated the stock have averaged $2.84 as their price target over the next twelve months.
In other news, Koppy Brian D, Chief Financial Officer sold 23,591 shares of the company’s stock on Apr 05. The stock was sold for $30,067 at an average price of $1.27. Upon completion of the transaction, the Chief Financial Officer now directly owns 802,570 shares in the company, valued at $1.04 million. Insiders disposed of 11,165,519 shares of company stock worth roughly $14.4 million over the past 1 year. A total of 11.80% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in CANO stock. A new stake in Cano Health Inc. shares was purchased by DIAMETER CAPITAL PARTNERS LP during the first quarter worth $27,891,000. NORGES BANK invested $3,409,000 in shares of CANO during the first quarter. In the first quarter, GLENVIEW CAPITAL MANAGEMENT, LLC acquired a new stake in Cano Health Inc. valued at approximately $1,226,000. SQUAREPOINT OPS LLC acquired a new stake in CANO for approximately $918,000. BAYESIAN CAPITAL MANAGEMENT, LP purchased a new stake in CANO valued at around $173,000 in the second quarter. In total, there are 239 active investors with 68.60% ownership of the company’s stock.
Cano Health Inc. (NYSE: CANO) opened at $1.4200 on Thursday. During the past 12 months, Cano Health Inc. has had a low of $0.76 and a high of $9.75. The fifty day moving average price for CANO is $1.2142 and a two-hundred day moving average price translates $2.9374 for the stock.
The latest earnings results from Cano Health Inc. (NYSE: CANO) was released for Mar, 2023. According to the Medical Care Facilities Company, earnings per share came in at -$0.12, inline with analysts’ expectations of -$0.12. This compares to $0.00 EPS in the same period last year. The net profit margin was -8.10% and return on equity was -69.80% for CANO. The company reported revenue of $866.91 million for the quarter, compared to $704.34 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 23.08 percent. For the current quarter, analysts expect CANO to generate $826.34M in revenue.
Cano Health Inc.(CANO) Company Profile
Cano Health, Inc. provides primary care medical services to its members in the United States and Puerto Rico. It owns and operates medical centers enabled by CanoPanorama, a proprietary population health management technology-powered platform that provides the healthcare providers at its medical centers with a 360-degree view of their members with actionable insights to improve care decisions and member engagement. The company also operates pharmacies, as well as provides dental services in its medical centers. Cano Health, Inc. was founded in 2009 and is headquartered in Miami, Florida.
